Open Beta
TREN
MetriLume
TREN

US marketsBCYC

SEC-sourced researchBeta

BCYC

BICYCLE THERAPEUTICS PLC

Company comparison ↗

Data passport

CIK
0001761612
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 26,976,000.0000 USD; December 2024: 35,275,000.0000 USD; December 2025: 72,586,000.0000 USD72.6M USD0 USD0December 2023December 2024December 2025
BCYC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202326,976,000.0000Mar 17, 2026
December 202435,275,000.0000Mar 17, 2026
December 202572,586,000.0000Mar 17, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202572,586,000.0000-218,960,000.0000-249,675,000.0000717,597,000.0000107,620,000.0000Mar 17, 2026
December 202435,275,000.0000-169,031,000.0000-164,724,000.0000956,868,000.0000163,808,000.0000Mar 17, 2026
December 202326,976,000.0000-180,664,000.0000-60,628,000.0000——Mar 17, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

57/100
Profitability0
Growth100
Balance sheet85
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$72.59MJan 1, 2025 – Dec 31, 2025Mar 17, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$35.28MJan 1, 2024 – Dec 31, 2024Mar 17, 202610-K
Net incomeNetIncomeLoss-$218.96MJan 1, 2025 – Dec 31, 2025Mar 17, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$249.68MJan 1, 2025 – Dec 31, 2025Mar 17, 202610-K
Total assetsAssets$717.6MDec 31, 2025Mar 17, 202610-K
Total liabilitiesLiabilities$107.62MDec 31, 2025Mar 17, 202610-K

New filings

Explore methodology ↗